Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells.
about
Potential role for metformin in urologic oncologyAdaptive responses of androgen receptor signaling in castration-resistant prostate cancerNutrition, dietary interventions and prostate cancer: the latest evidenceAssessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancerMetabolic Syndrome and Prostate Cancer: a Review of Complex Interplay Amongst Various Endocrine Factors in the Pathophysiology and Progression of Prostate Cancer.Metformin and Prostate Cancer: a New Role for an Old Drug.Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma.A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signalingMetformin: A Bridge between Diabetes and Prostate Cancer.Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells.Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau).Mechanism of midline defect-causing mutation P151L in MID1 revealed.Inhibition of the MID1 protein complex: a novel approach targeting APP protein synthesis.Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease
P2860
Q26747759-702D5E69-402B-4C8D-B646-F953D0680CF6Q26795625-61A951B6-91A9-44D9-85F6-995689C69C76Q28084566-D741FFD1-3B94-4A8F-8F7C-7A60F997D426Q30000285-0712B625-6788-4E86-81B5-F04DA43AD4DBQ35818232-5C9572D3-093D-4B9B-B3B2-99FF03F9A985Q38627406-FC776134-40CA-46E9-8602-578DFCCDF30FQ38819039-40CEBA84-9C1D-404C-96B2-DAB288D92037Q38884530-76B0321B-8B15-46CC-8C3C-742420AFBF67Q38942795-C78D7496-4421-4935-9451-099FFF0AF5D4Q38986420-054D96E3-A7A9-41A0-9010-9072376BD3B8Q42700292-A363BD4D-33BE-422D-A738-DB0E9AB2A85AQ42758453-05D73756-B117-4DDA-99A0-4A5E1F9552E0Q44441338-A5F4694F-7354-4260-83B7-7CDF37070C53Q50887075-C02EAC00-0339-4473-9632-5B62451AF9EFQ52358139-6AEA9FDB-E12F-4B44-9B9D-14330F79CA77Q58764354-47E5C7F5-6323-4012-B51F-F1F6A914233C
P2860
Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Metformin anti-tumor effect vi ...... tion in prostate cancer cells.
@en
type
label
Metformin anti-tumor effect vi ...... tion in prostate cancer cells.
@en
prefLabel
Metformin anti-tumor effect vi ...... tion in prostate cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Metformin anti-tumor effect vi ...... tion in prostate cancer cells.
@en
P2093
Andrea Koehler
Helmut Klocker
Rainer Schneider
Susann Schweiger
Ummuhan Demir
P2860
P2888
P356
10.1186/1471-2407-14-52
P407
P577
2014-01-31T00:00:00Z
P5875
P6179
1015198971